Cargando...
Phenotypic diversity drives paracrine drug tolerance
Considerable clinical successes have been achieved in cancer treatment since the introduction of targeted therapies. However, almost inevitably tumors develop therapy resistance, which limits durable clinical responses. Tumors are often heterogeneous, and as a result, therapy‐resistant cells are pre...
Gardado en:
| Publicado en: | EMBO Mol Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5538330/ https://ncbi.nlm.nih.gov/pubmed/28694322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707956 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|